Óttar Rolfsson

Dr. Óttar Rolfsson

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
ITInes Thiele
Ines Thiele
NSNeil Swainston
Neil Swainston
RFRonan MT Fleming
Ronan MT Fleming
AHAndreas Hoppe
Andreas Hoppe
SSSwagatika Sahoo
Swagatika Sahoo
BPBernhard Ø Palsson
Bernhard Ø Palsson
The metabolic modeling community has curated information from five models to create the most comprehensive model of human metabolism to date. Multiple models of human metabolism have been reconstructed, but each represents only a subset of our knowledge. Here we describe Recon 2, a community-driven, consensus 'metabolic reconstruction', which is the most comprehensive representation of human metabolism that is applicable to computational modeling. Compared with its predecessors, the reconstruction has improved topological and functional features, including ∼2× more reactions and ∼1.7× more unique metabolites. Using Recon 2 we predicted changes in metabolite biomarkers for 49 inborn errors of metabolism with 77% accuracy when compared to experimental data. Mapping metabolomic data and drug information onto Recon 2 demonstrates its potential for integrating and analyzing diverse data types. Using protein expression data, we automatically generated a compendium of 65 cell type–specific models, providing a basis for manual curation or investigation of cell-specific metabolic properties. Recon 2 will facilitate many future biomedical studies and is freely available at http://humanmetabolism.org/ .

18 March 2014 in Analytical Chemistry
Verified
Journal Article
Open access
Giuseppe PagliaGiuseppe Paglia
Giuseppe Paglia
JWJonathan P. Williams
Jonathan P. Williams
LMLochana Menikarachchi
Lochana Menikarachchi
JTJ. Will Thompson
J. Will Thompson
RTRichard Tyldesley-Worster
Richard Tyldesley-Worster
Giuseppe AstaritaGiuseppe Astarita
Giuseppe Astarita
Metabolomics is a rapidly evolving analytical approach in life and health sciences. The structural elucidation of the metabolites of interest remains a major analytical challenge in the metabolomics workflow. Here, we investigate the use of ion mobility as a tool to aid metabolite identification. Ion mobility allows for the measurement of the rotationally averaged collision cross-section (CCS), which gives information about the ionic shape of a molecule in the gas phase. We measured the CCSs of 125 common metabolites using traveling-wave ion mobility-mass spectrometry (TW-IM-MS). CCS measurements were highly reproducible on instruments located in three independent laboratories (RSD < 5% for 99%). We also determined the reproducibility of CCS measurements in various biological matrixes including urine, plasma, platelets, and red blood cells using ultra performance liquid chromatography (UPLC) coupled with TW-IM-MS. The mean RSD was < 2% for 97% of the CCS values, compared to 80% of retention times. Finally, as proof of concept, we used UPLC–TW-IM-MS to compare the cellular metabolome of epithelial and mesenchymal cells, an in vitro model used to study cancer development. Experimentally determined and computationally derived CCS values were used as orthogonal analytical parameters in combination with retention time and accurate mass information to confirm the identity of key metabolites potentially involved in cancer. Thus, our results indicate that adding CCS data to searchable databases and to routine metabolomics workflows will increase the identification confidence compared to traditional analytical approaches.

3 November 2003 in PLOS Biology
Verified
Journal Article
Open access
PDF file
USUnnur Styrkarsdottir
Unnur Styrkarsdottir
JCJean-Baptiste Cazier
Jean-Baptiste Cazier
AKAugustine Kong
Augustine Kong
ÓRÓttar Rolfsson
Óttar Rolfsson
HLHelene Larsen
Helene Larsen
KSKari Stefansson
Kari Stefansson
Osteoporotic fractures are a major cause of morbidity and mortality in ageing populations. Osteoporosis, defined as low bone mineral density (BMD) and associated fractures, have significant genetic components that are largely unknown. Linkage analysis in a large number of extended osteoporosis families in Iceland, using a phenotype that combines osteoporotic fractures and BMD measurements, showed linkage to Chromosome 20p12.3 (multipoint allele-sharing LOD, 5.10; p value, 6.3 × 10−7), results that are statistically significant after adjusting for the number of phenotypes tested and the genome-wide search. A follow-up association analysis using closely spaced polymorphic markers was performed. Three variants in the bone morphogenetic protein 2 (BMP2) gene, a missense polymorphism and two anonymous single nucleotide polymorphism haplotypes, were determined to be associated with osteoporosis in the Icelandic patients. The association is seen with many definitions of an osteoporotic phenotype, including osteoporotic fractures as well as low BMD, both before and after menopause. A replication study with a Danish cohort of postmenopausal women was conducted to confirm the contribution of the three identified variants. In conclusion, we find that a region on the short arm of Chromosome 20 contains a gene or genes that appear to be a major risk factor for osteoporosis and osteoporotic fractures, and our evidence supports the view that BMP2 is at least one of these genes.

15 March 2007 in Journal of Molecular Biology
Verified
Journal Article
Closed access
Peter StockleyPeter Stockley
Peter Stockley
ÓRÓttar Rolfsson
Óttar Rolfsson
GTGary S. Thompson
Gary S. Thompson
GBGabriella Basnak
Gabriella Basnak
SFSimona Francese
Simona Francese
AAAlison E. Ashcroft
Alison E. Ashcroft

7 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAarash Bordbar
Aarash Bordbar
JYJames T. Yurkovich
James T. Yurkovich
Giuseppe PagliaGiuseppe Paglia
Giuseppe Paglia
ÓRÓttar Rolfsson
Óttar Rolfsson
Ólafur SigurjónssonÓlafur Sigurjónsson
Ólafur Sigurjónsson
BPBernhard O. Palsson
Bernhard O. Palsson
The increasing availability of metabolomics data necessitates novel methods for deeper data analysis and interpretation. We present a flux balance analysis method that allows for the computation of dynamic intracellular metabolic changes at the cellular scale through integration of time-course absolute quantitative metabolomics. This approach, termed “unsteady-state flux balance analysis” (uFBA), is applied to four cellular systems: three dynamic and one steady-state as a negative control. uFBA and FBA predictions are contrasted, and uFBA is found to be more accurate in predicting dynamic metabolic flux states for red blood cells, platelets, and Saccharomyces cerevisiae. Notably, only uFBA predicts that stored red blood cells metabolize TCA intermediates to regenerate important cofactors, such as ATP, NADH, and NADPH. These pathway usage predictions were subsequently validated through 13C isotopic labeling and metabolic flux analysis in stored red blood cells. Utilizing time-course metabolomics data, uFBA provides an accurate method to predict metabolic physiology at the cellular scale for dynamic systems.

29 September 2016 in Blood
Verified
Journal Article
Closed access
PDF file
Giuseppe PagliaGiuseppe Paglia
Giuseppe Paglia
ADAngelo D’alessandro
Angelo D’alessandro
ÓRÓttar Rolfsson
Óttar Rolfsson
Ólafur SigurjónssonÓlafur Sigurjónsson
Ólafur Sigurjónsson
ABAarash Bordbar
Aarash Bordbar
BPBernhard O. Palsson
Bernhard O. Palsson
Key Points: Eight extracellular biomarkers define the metabolic age of stored RBCs. Metabolomics defines a universal signature of RBC storage lesion.